|
US20160000902A1
(en)
*
|
2003-07-11 |
2016-01-07 |
Novavax, Inc. |
Combination vaccine for respiratory syncytial virus and influenza
|
|
PL2347775T3
(pl)
|
2005-12-13 |
2020-11-16 |
President And Fellows Of Harvard College |
Rusztowania do przeszczepiania komórek
|
|
WO2009002401A2
(en)
|
2007-06-21 |
2008-12-31 |
President And Fellows Of Harvard College |
Scaffolds for cell collection or elimination
|
|
PT2222710T
(pt)
|
2007-12-24 |
2016-11-02 |
Glaxosmithkline Biologicals Sa |
Antigénios de rsv recombinantes
|
|
US9370558B2
(en)
|
2008-02-13 |
2016-06-21 |
President And Fellows Of Harvard College |
Controlled delivery of TLR agonists in structural polymeric devices
|
|
JP5690143B2
(ja)
|
2008-02-13 |
2015-03-25 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
持続的細胞プログラミング装置
|
|
SI2370099T1
(sl)
*
|
2008-12-09 |
2016-08-31 |
Novavax, Inc. |
Modificirani proteini RSV F in postopki njihove uporabe
|
|
US11446374B2
(en)
|
2008-12-09 |
2022-09-20 |
Novavax, Inc. |
Modified RSV F proteins and methods of their use
|
|
SI2445526T1
(sl)
*
|
2009-06-24 |
2016-08-31 |
Glaxosmithkline Biologicals S.A. |
Rekombinantni RSV antigeni
|
|
CA2766205A1
(en)
*
|
2009-06-24 |
2010-12-29 |
Id Biomedical Corporation Of Quebec |
Vaccine comprising at least two paramyxovirus f protein antigens
|
|
JP5829210B2
(ja)
|
2009-07-15 |
2015-12-09 |
ノバルティス アーゲー |
Ｒｓｖｆタンパク質組成物およびそれを作製するための方法
|
|
EP2453903B1
(en)
*
|
2009-07-17 |
2016-08-17 |
Industry Academic Cooperation Foundation, Hallym University |
Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
|
|
WO2011014871A1
(en)
|
2009-07-31 |
2011-02-03 |
President And Fellows Of Harvard College |
Programming of cells for tolerogenic therapies
|
|
AU2010279492B2
(en)
*
|
2009-08-04 |
2015-04-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of The Health And Human Services, Centers For Disease Control And Prevention |
Anti-RSV immunogens and methods of immunization
|
|
WO2012006395A1
(en)
|
2010-07-07 |
2012-01-12 |
Artificial Cell Technologies, Inc. |
Respiratory syncytial virus antigenic compositions and methods
|
|
EP2624873B1
(en)
|
2010-10-06 |
2019-12-04 |
President and Fellows of Harvard College |
Injectable, pore-forming hydrogels for materials-based cell therapies
|
|
CA2825722A1
(en)
*
|
2011-01-28 |
2012-08-02 |
Medimmune, Llc |
Expression of soluble viral fusion glycoproteins in mammalian cells
|
|
CN103747797B
(zh)
*
|
2011-04-26 |
2017-06-09 |
分子表达公司 |
脂质体制剂
|
|
WO2012149358A1
(en)
|
2011-04-28 |
2012-11-01 |
President And Fellows Of Harvard College |
Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
PT2707385T
(pt)
|
2011-05-13 |
2017-12-19 |
Glaxosmithkline Biologicals Sa |
Antigénios de f de rsv pré-fusão
|
|
CA2838125A1
(en)
|
2011-06-03 |
2012-12-06 |
President And Fellows Of Harvard College |
In situ antigen-generating cancer vaccine
|
|
ES2395677B1
(es)
*
|
2011-07-29 |
2013-12-26 |
Instituto De Salud Carlos Iii |
Proteína F del VRSH en conformación pre-fusión estabilizada y anticuerpos neutralizantes específicos frente a la misma.
|
|
US9463236B2
(en)
|
2011-08-29 |
2016-10-11 |
Tokushima University |
RSV mucosal vaccine
|
|
EP2760469A4
(en)
*
|
2011-09-30 |
2015-03-18 |
Novavax Inc |
RECOMBINANT RSV-F NANOPARTICLE VACCINE AGAINST RESPIRATORY SYNZYTIAL VIRUS
|
|
CN104619719A
(zh)
*
|
2012-04-10 |
2015-05-13 |
宾夕法尼亚大学理事会 |
人呼吸道合胞病毒共有抗原、由其制备的核酸构建体和疫苗及其使用方法
|
|
DK2838515T3
(da)
|
2012-04-16 |
2020-02-24 |
Harvard College |
Mesoporøse siliciumdioxidsammensætninger til modulering af immunresponser
|
|
EA201891945A3
(ru)
*
|
2012-08-01 |
2019-05-31 |
Бавариан Нордик А/С |
Вакцина рекомбинантного модифицированного вируса осповакцины анкара (mva) респираторно-синцитиального вируса (rsv)
|
|
PT2879702T
(pt)
*
|
2012-08-01 |
2020-02-04 |
Bavarian Nordic As |
Vacina para o vírus sincicial respiratório (rsv) de vírus vaccinia modificado recombinante ankara (mva)
|
|
SG11201500573RA
(en)
|
2012-08-06 |
2015-02-27 |
Glaxosmithkline Biolog Sa |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
|
US20140037680A1
(en)
*
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
KR20150138184A
(ko)
*
|
2013-02-11 |
2015-12-09 |
노바백스, 인코포레이티드 |
호흡기 세포 융합 바이러스 및 인플루엔자를 위한 조합 백신
|
|
EP3492097A1
(en)
|
2013-08-05 |
2019-06-05 |
GlaxoSmithKline Biologicals S.A. |
Combination immunogenic compositions
|
|
EP3137105A4
(en)
|
2014-04-30 |
2017-12-27 |
President and Fellows of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
|
MX384992B
(es)
|
2014-06-13 |
2025-03-14 |
Glaxosmithkline Biologicals Sa |
Combinaciones inmunógenas.
|
|
HK1247861A1
(zh)
|
2015-01-30 |
2018-10-05 |
President And Fellows Of Harvard College |
用於癌症治疗的肿瘤周围和肿瘤内部材料
|
|
HK1249452A1
(zh)
|
2015-04-10 |
2018-11-02 |
President And Fellows Of Harvard College |
免疫细胞捕获装置及其制备和使用方法
|
|
EP4494650A3
(en)
|
2015-09-03 |
2025-03-26 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
|
RU2723039C2
(ru)
|
2015-12-23 |
2020-06-08 |
Пфайзер Инк. |
Мутанты белка f rsv
|
|
CN115531609A
(zh)
|
2016-02-06 |
2022-12-30 |
哈佛学院校长同事会 |
重塑造血巢以重建免疫
|
|
DK3484448T3
(da)
|
2016-07-13 |
2025-06-10 |
Harvard College |
Antigenpræsenterende cellemimetiske stilladser og fremgangsmåder til fremstilling og brug af disse
|
|
IL264557B2
(en)
|
2016-08-02 |
2024-01-01 |
Harvard College |
Biological agents for regulating immune responses
|
|
CN109790561B
(zh)
|
2016-08-03 |
2024-02-06 |
隆萨沃克斯维尔股份有限公司 |
利用基本上不含凝固蛋白原的鲎阿米巴样细胞溶解物检测内毒素的方法
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
US11352656B2
(en)
*
|
2017-01-11 |
2022-06-07 |
Lonza Walkersville, Inc. |
Coagulogen-free clarified limulus amebocyte lysate and chromogenic assay of endotoxin
|
|
EP3658118B1
(en)
|
2017-07-24 |
2025-03-19 |
Novavax, Inc. |
Methods and compositions for treating respiratory disease
|
|
WO2019076892A1
(en)
|
2017-10-16 |
2019-04-25 |
Glaxosmithkline Biologicals Sa |
ENHANCED PROMOTER
|
|
BR112020007413A2
(pt)
|
2017-10-16 |
2020-12-08 |
Glaxosmithkline Biologicals S.A. |
Vetores adenovirais com dois cassetes de expressão
|
|
CA3079048A1
(en)
|
2017-10-16 |
2019-04-25 |
Glaxosmithkline Biologicals Sa |
Adenoviral vectors with two expression cassettes encoding rsv antigenic proteins or fragments thereof
|
|
US11905313B2
(en)
|
2017-11-28 |
2024-02-20 |
The United States of America, as represented by the Secretary, Department of Health and Human Services. |
Recombinant RSV G proteins and their use
|
|
JP7417532B2
(ja)
|
2018-03-19 |
2024-01-18 |
ノババックス，インコーポレイテッド |
多価インフルエンザナノ粒子ワクチン
|
|
MX2020013553A
(es)
|
2018-06-12 |
2021-02-26 |
Glaxosmithkline Biologicals Sa |
Polinucleotidos y polipeptidos de adenovirus.
|
|
WO2020061129A1
(en)
|
2018-09-19 |
2020-03-26 |
President And Fellows Of Harvard College |
Compositions and methods for labeling and modulation of cells in vitro and in vivo
|
|
KR102725189B1
(ko)
|
2018-11-01 |
2024-10-31 |
에스케이바이오사이언스(주) |
재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물
|
|
WO2020175660A1
(ja)
|
2019-02-28 |
2020-09-03 |
Ｋｍバイオロジクス株式会社 |
Ｒｓｖ ｆ／ｇキメラワクチン
|
|
JP2022549270A
(ja)
|
2019-09-23 |
2022-11-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
バイオマテリアルベースの無抗原ワクチンおよびその使用
|
|
CN114993784B
(zh)
*
|
2022-05-27 |
2025-07-29 |
重庆医科大学 |
一种乙肝病毒颗粒裂解液及其制备与应用
|
|
WO2025263563A1
(ja)
*
|
2024-06-20 |
2025-12-26 |
Ｋｍバイオロジクス株式会社 |
ＲＳＶ ＦＧキメラｍＲＮＡワクチン
|